SHIM compared with VRCA: revenue, margins and what each company keeps, and the suppliers and customers both name

SHIMShimmick Corp

Mkt capRevenueRevenue

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

SHIMShimmick Corp

VRCAVerrica Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SHIM 0

None

Shared 0

No disclosed counterparties: SHIM.

Only VRCA 1

—Lytix BioPharma ASunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

SHIMShimmick Corp

2.51· pre 2.51· delayed

Mkt cap$103.8MRevenue$142MQ3 FY26Revenue$633MFY23

VRCAVerrica Pharmaceuticals Inc.

3.20· pre 3.27· delayed

Pre-marketNov 2 '26delayed

Mkt cap$55.1MRevenue$6MQ2 FY26Revenue$36MFY25

Compare

Pre-marketNov 2 '26delayed

SHIMShimmick Corp

VRCAVerrica Pharmaceuticals Inc.

2.51pre 2.51delayed

Price

3.20pre 3.27delayed

$103.8M

Mkt cap

$55.1M

Q3 FY26$142M

Revenue

$6MQ2 FY26

FY23$633M

Revenue

$36MFY25

SHIM2.51vsVRCA3.20Pre-marketNov 2 '26delayed